Synthesis of Drug Substance
Arcinova provides full synthesis of drug substance and support services to big pharma, specialty pharma and biotechnology companies as an unique, integrated provider of chemistry, biology and process technology.
We run a one stop development and kilo scale manufacturing facility, ensuring a service provision of manufacturing processes which can be scaled from grams to multi kilos. We are strong in route selection, process development and impurity tracking / control through our onsite process chemistry, radiolabelled synthesis, analytical and drug development teams. We innovatively develop bespoke solutions for technically difficult challenges and give our customers a better deal in terms of speed, cost and quality.
Arcinova have over 30 years’ experience in the synthesis of labelled pharmaceutical and non-pharmaceutical molecules critical to successfully achieving key development milestones. Our highly trained chemists have extensive chemical and radiochemical knowledge, providing consultancy and advice on the most suitable labelling positions for a variety of molecular entities.
Whether you need isotopically labelled compounds for the conduct of non-clinical or clinical metabolism studies, the quantification of materials in biological matrices or to determine environmental fate and effect, our expertise provides the necessary labelled materials tailored to support your studies.
Our custom labelling synthesis services benefit from synergies with a range of other services. API Development allows for provision of key intermediates for labelling work. With formulation development, IMP manufacture and dossier writing expertise on site, there is great flexibility for integrating the provision of labelled materials with your development programme.
Custom Process Research, Development and Scale-up
Arcinova continue to invest heavily in people, technology and facilities and can offer 1-20kg scale GMP API development and manufacturing capability.
Isotopic Labelling Services
Arcinova offer both radiolabelling (including 14C) and stable isotopic labelling services.
SMi Highly Potent Active Pharmaceutical IngredientsThe SMi Highly Potent Active Pharmaceutical Ingredients Conference will be attended by Mark Anstiss, Scale-up Chemist.
SMi Highly Potent Active Pharmaceutical IngredientsDates: 21st - 22nd MayLocation: Birmingham, UK
66th Annual ASMS ConferenceThe 66th ASMS Conference on Mass Spectrometry and Allied Topics Conference will be attended by Michael Blackburn, Method Development Scientist (Physiochemical). Michael will also be presenting during the conference, at the Proteins & Peptides Waters Users Meeting, with a presentation entitled; A Powerful Hybrid IA-LC-MS/MS Method Quantification of Insulin Analogues and
66th Annual ASMS ConferenceDates: 3rd - 7th JuneLocation: San Diego, US
2018 BIO International ConventionThe 2018 BIO International Convention will be attended by Mark Chadwick, Head of Business Development.
2018 BIO International ConventionDates: 4th - 7th JuneLocation: Boston, USA